Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine disorder characterized by chronic anovulation, hyperandrogenism, and insulin resistance. Beyond reproductive dysfunction, its metabolic underpinnings predispose affected women to obesity, type 2 diabetes, hypertension, and broader cardiometabolic risk. Menstrual irregularity, frequently associated with hyperinsulinemia and glycemic disturbances, may serve as a clinical proxy for underlying metabolic dysfunction in PCOS.
Although lifestyle modification through diet and exercise remains the cornerstone of management, long-term adherence is often difficult, limiting sustained reproductive and metabolic benefits. Emerging technology, leveraging artificial intelligence (AI) and Internet of Things (IoT) integration, offers a precision-based approach by predicting personalized postprandial glucose responses and delivering…
